Related Experiment Video
Updated: Mar 25, 2026

Developing a Behavioral Box for Assessing Prepulse Inhibition and Neural Activity in Psychiatric Animal Models
Published on: July 22, 2025
The ICU environment paradigm as a strategy to enhance the validity of delirium animal models
Diogo Dominguini1,2, Carla Sasso Simon1, Daniel Paulo Bortoluzzi1
1Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, University of Southern Santa Catarina, Criciúma, SC, Brazil.
Abstract:
Delirium is common in ICU patients and associated with adverse outcomes. We hypothesized that an ICU-like environment would enhance model validity by amplifying behavioral and neurobiological alterations. Male Wistar rats (50 days old) underwent sterile laparotomy or cecal ligation and puncture (CLP)-induced sepsis, with or without exposure to an ICU-like environment. Behavioral tests (open field, Y-maze, SHIRPA) were performed at 0-36 h, along with assessments of reactive oxygen species, glial markers, neurotransmitters, and delirium incidence/severity. Predictive validity was evaluated in the most severe condition (CLP + ICU) using minocycline, dexmedetomidine, and rivastigmine. The ICU-like environment exacerbated behavioral deficits consistent with human delirium and increased their severity. We observed elevations in IL-6 (hippocampus, cortex, and plasma in laparotomy; hippocampus in sepsis) and IL-1β (cortex in laparotomy), alongside aminergic/excitatory imbalance (dopamine, noradrenaline, and glutamate). In sepsis + ICU, minocycline and dexmedetomidine reduced IL-1β/IL-6 and improved behavioral performance; rivastigmine improved selected behavioral domains, increased acetylcholine, and reduced AChE activity; dexmedetomidine decreased ROS; and minocycline and rivastigmine attenuated microgliosis. The ICU-like environment worsened behavioral and neurochemical changes, surgery plus anesthesia, and sepsis, supporting its value for enhancing model validity.
More Related Videos
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018